Dermatology experts note that although telogen effluvium is extremely distressing, for most people it is temporary and resolves on its own, with hair returning to close to baseline
Common tirzepatide concentrations include 5mg/mL, 10mg/mL, and 15mg/mL, and the unit calculation is identical: divide your dose in milligrams by the concentration in mg/mL, then multiply by 100
Chattopadhyay I, Gundamaraju R, Jha NK, et al
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
)
)
